Short interest in Teleflex Incorporated (NYSE: TFX) increases 25.8%

Teleflex Incorporated (NYSE: TFX) benefited from strong growth in short-term interest during the month of October. As of October 29, there was short interest totaling 738,700 shares, an increase of 25.8% from the total of 587,400 shares as of October 14. Based on an average trading volume of 272,700 shares, the short-term interest rate is currently 2.7 days. Currently 1.6% of the company’s shares are sold short.

Teleflex shares traded down $ 11.16 in Friday’s session, reaching $ 318.83. The company had a trading volume of 698,394 shares, compared to an average volume of 265,328. The company has a market capitalization of $ 14.94 billion, a price / earnings ratio of 34.84 and a beta of 1.08. . The company’s fifty-day moving average is $ 365.02 and its 200-day moving average is $ 384.88. The company has a debt to equity ratio of 0.53, a quick ratio of 1.88, and a current ratio of 2.74. Teleflex has a 52-week low of $ 318.19 and a 52-week high of $ 449.38.

Teleflex (NYSE: TFX) last released its results on Thursday, October 28. The medical technology company reported EPS of $ 3.51 for the quarter, beating the consensus estimate of $ 3.03 by $ 0.48. The company posted revenue of $ 700.25 million in the quarter, compared to $ 698.25 million expected by analysts. Teleflex has a net margin of 15.71% and a return on equity of 17.78%. Teleflex’s quarterly revenue increased 11.5% year-on-year. In the same quarter of the previous year, the company achieved EPS of $ 2.77. On average, research analysts predict Teleflex will post 13.26 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 15. Shareholders of record on Monday, November 15 will receive a dividend of $ 0.34 per share. The ex-dividend date is Friday, November 12. This represents an annualized dividend of $ 1.36 and a dividend yield of 0.43%. Teleflex’s dividend payout ratio (DPR) is 14.86%.

(A d)

Teeka Tiwari – the man voted # 1 most trusted crypto expert – just made a SKY-HIGH crypto prediction.

In this new show, recorded live in Miami… Teeka today reveals her CRYPTO MUST-OWN # 1…

In other Teleflex news, Vice President Cameron P. Hicks sold 3,600 shares of the company in a trade on Wednesday, November 10. The stock was sold at an average price of $ 350.00, for a total transaction of $ 1,260,000.00. The transaction was disclosed in a file with the SEC, accessible through this hyperlink. 1.34% of the shares are currently held by insiders of the company.

Institutional investors and hedge funds have recently changed their positions in the company. Harel Insurance Investments & Financial Services Ltd. acquired a new position in Teleflex in the 3rd quarter for a value of $ 26,000. Highlander Capital Management LLC purchased a new position in Teleflex shares during the 2nd quarter valued at approximately $ 40,000. Group One Trading LP purchased a new position in Teleflex shares during the second quarter valued at approximately $ 40,000. Evolution Wealth Advisors LLC increased its stake in Teleflex shares by 60.3% during the 2nd quarter. Evolution Wealth Advisors LLC now owns 109 shares of the medical technology company valued at $ 44,000 after acquiring 41 additional shares during the period. Finally, Berman Capital Advisors LLC increased its position in Teleflex shares by 210.5% during the second quarter. Berman Capital Advisors LLC now owns 118 shares of the medical technology company valued at $ 47,000 after purchasing 80 more shares in the last quarter. Institutional investors hold 94.65% of the shares of the company.

TFX has been the subject of several analyst reports. Raymond James reduced his price target on Teleflex from $ 440.00 to $ 391.00 and set an “outperform” rating for the company in a report released on Friday October 29th. SVB Leerink raised its target price on Teleflex from $ 410.00 to $ 415.00 and assigned the stock a “market performance” rating in a Friday July 30th research note. JMP Securities lowered its price target on Teleflex from $ 470.00 to $ 430.00 and established a “market outperformance” rating for the company in a Friday October 29th research note. Jefferies Financial Group began covering Teleflex in a research note on Friday, September 10. They set a “buy” rating and a price target of $ 485.00 for the company. Finally, Zacks Investment Research downgraded Teleflex from a “custody” rating to a “sell” rating and set a price target of $ 396.00 for the company. in a research report on Tuesday, October 26. One analyst assigned a sell rating to the stock, another assigned a conservation rating, and nine assigned a buy rating to the stock. Based on data from, the company currently has an average rating of “Buy” and an average target price of $ 440.73.

About Téléflex

Teleflex, Inc provides medical technology products that enable healthcare providers to improve patient outcomes and improve patient and provider safety. The company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.

Recommended story: what is the book value of a stock?

This instant news alert was powered by storytelling technology and MarketBeat financial data to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $ 1,000 in Teleflex now?

Before you consider Teleflex, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts quietly whisper to their clients to buy now before the wider market takes hold … and Teleflex was not on the list.

While Teleflex currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here

Comments are closed.